Lord Abbett Micro Cap Growth Fund (LCMGX)

NASDAQ · Mutual Fund · Delayed Price · Currency is USD
18.83
+0.41 (2.23%)
May 12, 2025, 4:00 PM EDT
7.48%
Fund Assets 192.98M
Expense Ratio 2.13%
Min. Investment $1,500
Turnover n/a
Dividend (ttm) n/a
Dividend Yield n/a
Dividend Growth n/a
Payout Frequency n/a
Ex-Dividend Date n/a
Previous Close 18.42
YTD Return -9.73%
1-Year Return 7.48%
5-Year Return n/a
52-Week Low n/a
52-Week High n/a
Beta (5Y) n/a
Holdings 75
Inception Date Aug 28, 2020

About LCMGX

LCMGX was founded on 2020-08-28. The Fund's investment strategy focuses on Micro-Cap. The minimum amount to invest in Lord Abbett Securities Trust: Lord Abbett Micro Cap Growth Fund; Class C Shares is $1,500 on a standard taxable account. Lord Abbett Securities Trust: Lord Abbett Micro Cap Growth Fund; Class C Shares seeks long-term capital appreciation by investing at least 80% of its assets in equity securities of companies with market capitalizations of less than $350 million at the time of purchase. LCMGX will invest in micro-cap companies that have the potential for more rapid growth than the overall economy.

Category Small Growth
Performance Rating Below Average
Risk Rating Above Average
Stock Exchange NASDAQ
Ticker Symbol LCMGX
Share Class Class C
Index Russell Microcap Growth TR

Performance

LCMGX had a total return of 7.48% in the past year, including dividends. Since the fund's inception, the average annual return has been 8.04%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol Share Class Expense Ratio
LMIYX Class I 1.13%
LFMGX Class F 1.13%
LAMGX Class A 1.38%

Top 10 Holdings

26.85% of assets
Name Symbol Weight
Universal Technical Institute, Inc. UTI 3.28%
Tarsus Pharmaceuticals, Inc. TARS 3.19%
GeneDx Holdings Corp. WGS 3.00%
The Chefs' Warehouse, Inc. CHEF 2.79%
OSI Systems, Inc. OSIS 2.71%
Scholar Rock Holding Corporation SRRK 2.45%
Natural Grocers by Vitamin Cottage, Inc. NGVC 2.42%
Grindr Inc. GRND 2.41%
Alkami Technology, Inc. ALKT 2.34%
Mirum Pharmaceuticals, Inc. MIRM 2.27%
View More Holdings